Filing metadata

Accession number
0001683168-24-002047
Form type
Form 5
Filer
Altamont Pharmaceutical Holdings, LLC
CIK
CIK 1745878
Filed
Apr 01, 2024
Reporting period
Dec 31, 2023
Description
Annual insider statement

Explore SEC Filings Hub